Katie Price has spoken about reaching out to her son Harvey's half-brother, Orlando Yorke, and how she couldn't believe how ...

Discover key insights from Soleno Therapeutics' Q2 2025 earnings call, highlighting Vykat XR's strong launch, revenue growth, EU expansion efforts & ...

New approach finds ‘parent-of-origin’ effects in more than a dozen genes — without the need for parental data.

Announced submission and validation of Marketing Authorization Application (MAA) submission to the European Medicines Agency (EMA) seeking marketing approval of DCCR (marketed in the U.S. as VYKAT XR) ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2025.

Katie Price's son Harvey made fans emotional after his father celebrated his younger child's birthday and seemingly ignored ...

Conference Call Information Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its second quarter 2025 financial results and recent business activities ...

We came across a bullish thesis on Harmony Biosciences Holdings, Inc. on In. Specter’s Substack. In this article, we will ...

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

Four years before Kimberly Gallagher enrolled in Medicaid herself, the public health insurance program’s rules prompted her ...

KATIE Price has opened up about an emotional week after eldest son Harvey finished college and moved to his new home in ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for treating adults with growth hormone deficiency (GHD).This ...